Mechanisms and Prevention of Alloimmunization in Pregnancy
Authors:
- Jens Kjeldsen-KraghJKJens Kjeldsen-Kragh
- Bjørn SkogenBSBjørn Skogen
- 1 July 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 68 (7) , 526-532
Abstract
Transfusion only occasionally gives rise to antibody production, because blood cells per se are not markedly immunogenic. However, the immunological changes that occur during pregnancy increase the risk of alloimmunization against red blood cells, platelets, and/or leukocytes. Fetal-maternal bleeding during pregnancy or in relation to delivery is the antigenic stimuli for immunization against red blood cells, whereas other mechanisms, such as trophoblast-derived microparticles, may also play a role in the production of antibodies against platelets. Antibody-mediated immune suppression has for 4 decades successfully been used for prevention of RhD immunization. Result from a mouse model of fetal and neonatal alloimmune thrombocytopenia (FNAIT) suggests that the same principle may be applied for the prevention of FNAIT. A European Union-funded consortium is presently in the process of developing a hyperimmune anti-human platelet antigen 1a (HPA-1a) immunoglobulin G. The idea is to prevent HPA-1a immunization by administering the drug to nonimmunized HPA-1a-negative women after delivery of an HPA-1a-positive child. The anti-HPA-1a will be purified from plasma collected from women who previously have given birth to a child with FNAIT caused by anti-HPA-1a. If the results of the planned phase III trial are favorable, it is possible that a product for prevention of FNAIT will be available within this decade.Keywords
This publication has 42 references indexed in Scilit:
- Dendritic Cells and Damage-Associated Molecular Patterns: Endogenous Danger Signals Linking Innate and Adaptive ImmunityJournal of Innate Immunity, 2011
- Report of the first nationally implemented clinical routine screening for fetal RHD in D− pregnant women to ascertain the requirement for antenatal RhD prophylaxisTransfusion, 2011
- Human Decidual Tissue Contains Differentiated CD8+ Effector-Memory T Cells with Unique PropertiesThe Journal of Immunology, 2010
- Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic reviewBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Transfusion-related Acute Lung Injury During Intravenous Immunoglobulin TreatmentThe Journal of Rheumatology, 2009
- Specificities of leucocyte alloantibodies in transfusion‐related acute lung injury and results of leucocyte antibody screening of blood donorsVox Sanguinis, 2008
- Trophoblast Deportation in Human Pregnancy—its Relevance for Pre-eclampsiaPlacenta, 1999
- CD28/B7 SYSTEM OF T CELL COSTIMULATIONAnnual Review of Immunology, 1996
- A prospective study to determine the frequency and clinical significance of alloimmunization post‐transfusionBritish Journal of Haematology, 1995
- Experimental Studies on the Prevention of Rh Haemolytic DiseaseBMJ, 1961